A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

The FDA's ODAC voted unanimously against the risk-benefit profile of talazoparib and enzalutamide for the treatment of mCRPC ...

Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant ...

The FDA’s ODAC has voted against the risk/benefit profile of two targeted therapies for the treatment of bladder and prostate ...

NHS England has committed to implementing the recommendations of the Infected Blood Inquiry, through identifying all those infected with a blood-borne disease, however it is transmitted, and set out ...

In making his way back from blood clots in his right shoulder, the San Antonio Spurs' generational talent looked at the first step with a sense of awe. “Looking back, I'm really lucky,” the 7 ...

I'm Andy Gaither. The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the ...